Inhibition of glucocorticoid receptor binding by nitric oxide

Molecular Pharmacology

Volumn 55, Issue 2, 1999, Pages 317-323

  Galigniana, Mario D ^a   Piwien Pilipuk, Graciela ^a   Assreuy, Jamil ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DITHIOTHREITOL; GLUCOCORTICOID RECEPTOR; NITRIC OXIDE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; DRUG EFFECT; DRUG INHIBITION; DRUG RECEPTOR BINDING; ENZYME INDUCTION; IMMUNOPRECIPITATION; LIGAND BINDING; MOUSE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SEPTIC SHOCK; TISSUE PERFUSION;

EID: 0033053615     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.55.2.317     Document Type: Article

References (35)

1. + donation by S-nitrosothiols: Implications for regulation of physiological functions by S-nitrosothiols and acceleration of disulfide formation. Arch Biochem Biopkys 318:279-275.
2. Auphan N, DiDonato JA, Rosette C, Helmberg A and Karin M (1995) Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science (Wash DC) 270:286-290.
3. Beckman JS, Chen J, Ischiropoulos H and Crow JP (1994) Oxidative chemistry of peroxynitrite. Methods Enzymol 233:299-241.
4. Bone CB (1991) Gram-negative sepsis. Background, clinical features, and intervention. Chest 100:802-808.
5. Brandtzaeg P (1906) Significance and pathogenesis of septic shock, in Pathophysiology of Septic Shock. Current Topics in Microbiology and Immunology (Rietschel ET and Wagner H eds) vol 216, pp 16-37, Springer Verlag, Berlin.
6. Bredt DS and Snyder SH (1990) Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA 87:682-685.
7. Cohen J and Glauser MP (1991) Septic shock: Treatment. Lancet 338:736-739.
8. De Bosscher K, Schmitz ML, van den Berghe W, Plaisance S, Fiers W and Haegeman G (1997) Glucocorticoid-mediated repression of nuclear factor-kappa B-dependent transcription involves direct interference with transactivation. Proc Natl Acad Sci USA 94:13504-13509.
9. Fang F (1997) Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 99:2818-2825.
10. Field L, Dilts RV, Ravichandran R, Lenhert PG and Carnahan GE (1978) An unusually stable thionitrite from N-acetyl-D, L-penicillamine; X-ray crystal and molecular structure of 2-(acetylamino)-2-carboxy-1,1-dimethylethyl thionitrite. J Chem Soc Commun 249-250.
11. Fukuto JM and Chaudhuri G (1995) Inhibition of constitutive and inducible nitric oxide synthases: Potential selective inhibition. Annu Rev Pharmacol Toxicol 35: 165-194.
12. Galigniana MD (1996) Stability study on renal type I mineralocorticoid receptor. Life Sci 59:511-521.
13. Hart TW (1985) Some observations concerning the S-nitroso and S-phenylsulphonyl derivatives of L-cysteine and glutatbione. Tetrahedron Lett 26:2013-2016.
14. 3H]thymidine uptake by rat thymocytes and 3T3 cells in vitro. Mol Cell Endocrinol 61:133-138.
15. Huang ZH. Gao H and Xu RB (1987) Study on glucocorticoid receptors during intestinal ischemia shock and septic shock. Circ Shock 23:27-36.
16. Kleinert H, Euchehofer C, Ihrig-Biedert I and Forstermann U (1996) Glucocorticoids inhibit the induction of nitric oxide synthase II by down-regulating cytokine-induced activity of transcription factor nuclear factor kappa B. Mol Pharmacol 49:15-21.
17. Li F and Xu RB (1988) Changes in canine leukocyte glucocorticoid receptors during endotoxin shock. Circ Shock 26:99-105.
18. Molijn GJ, Koper JW, van Uffelen CJ, de Jong FH, Brinkmann AO, Bruining HA and Lamberts SW (1995) Temperature-induced down-regulation of the glucocorticoid receptor in peripheral blood mononuclear leucocyte in patients with sepsis or septic shock. Clin Endocrinol 43:197-203.
19. Moncada S, Palmer RMJ and Higgs EA (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
20. Parrillo JE (1993) Pathogenetic mechanisms of septic shock. N Engl J Med 328: 1471-1477.
21. Pugeat M, Bonneton A, Perrot D, Rocle-Nicolas B, Lejeune H, Grenot C, Dechaud H, Brebant C, Motin J and Cuilleron CY (1989) Decreased immunoreactivity and binding activity of corticosteroid-binding immunoglobulin in serum in septic shock. Clin Chem 35:1675-1679.
22. Rees DD, Cellek S, Palmer RMJ and Moncada S (1990) Dexamethasone prevents the induction by endotoxin of a nitric oxide synthase and the associated effects on vascular tone: An insight into endotoxin shock. Biochem Biophys Res Commun 173:541-547.
23. Rees DD (1995) Role of nitric oxide in the vascular dysfunction of septic shock. Biochem Soc Trans 23:1025-1029.
24. 13C-nMr spectroscopy. J Steroid Biochem 15:467-472.
25. Saura M, Zaragoza C, Diaz-Cazoria M, Hernandez-Pereira O, Eng E, Lowenstein CJ, Perez-Sala D, Lamas S (1998) Involvement of transcriptional mechanisms in the inhibition of NOS2 expression by dexamethasone in rat mesangial cells. Kidney Int 53:38-49.
26. Saville B (1958) A scheme for the colorimetric determination of microgram amounts of thiols. Analyst 83:670-672.
27. Scheinman RI, Cogswell PC, Lofquist AK and Baldwin AS (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science Wash DC 270:283-286.
28. Simons SS and Pratt WB (1995) Glucocorticoid receptor thiols and steroid-binding activity. Methods Enzymol 251:406-422.
29. Spack L, Havens PL and Griffith OW (1997) Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome. Crit Care Med 25:1071-1078.
30. 125I]iodotyrosine to demonstrate conformational differences between the unbound and hsp90-bound glucocorticoid receptor hormone binding domain. J Biol Chem 271:8831-8836.
31. Thijs LG, Groeneveld ABJ and Hack CE (1996) Multiple organ failure in septic shock, in Pathophysiology of Septic Shock. Current Topics in Microbiology and Immunology (Rietschel ET and Wagner H eds) vol 216, pp 209-237, Springer Verlag, Berlin.
32. Thompson J (1993) Role of glucorticosteroids in the treatment of infectious diseases. Eur J Clin Microbiol & Infect Dis 12:S68-S72.
33. Welch G and Loscalzo J (1994) Nitric oxide and the cardiovascular system. J Cardiovasc Surg 9:361-371.
34. Wissink S, van Heerde EC, van der Burg B and van der Saag PT (1998) A dual mechanism mediates repression of NF-kappa B activity by glucocorticoids. Mol Endocrinol 12:355-363.
35. Wright CE, Rees DD and Moncada S (1992) Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res 26:48-57.